Impact of Three Continuing Education Meetings for Community Pharmacists on Weight Management

July 25, 2011 updated by: Tehran University of Medical Sciences

Evaluation of Three 1-day Educational Intervention to Promote Knowledge and Attitude of Community Pharmacists About Evidence-based Weight Management

This study is a three-arm randomized controlled trial to evaluate the effects of 1-day continuing educational meetings for community pharmacists with three distinct educational methods: 1) Didactic lecture 2) Didactic lecture plus case discussion in a large group 3) Didactic lecture plus small group education with simulated patient

Knowledge and attitude of the participants would be measured as the study outcome in three periods: pre-education, post-education and 1 month after the meetings.

Study Overview

Detailed Description

The study is designed as an Instructor blinded-Randomized Controlled Trial.

An educational need assessment is undergone prior to educational content preparation by interviewing 5 community pharmacists. After educational content preparation by instructors, the outcome assessment tool (knowledge, attitude questionnaire) would be designed by a distinct investigator. Closed and Open-ended questions are included to investigate different levels of Bloom's taxonomy.

The questionnaire would be validated by specialists other than the instructors and it will piloted to investigate the reliability( Cronbach's Alfa > 0.7).

Community pharmacists of Tehran,Capital city of Iran, would be invited to participate in the study. The participants would be randomly assigned to 3 groups by random number table. Each group receives the same education content with a different method:

  1. Didactic lecture
  2. Didactic lecture plus case discussion in a large group
  3. Didactic lecture plus small group education with simulated patient(SP). Interviewing with SP is conducted by small group facilitators with Brain Storming Technic.

Each participant receives a compact disk which includes the educational material and he/she would be able to contact the instructors by phone or e-mail during the follow-up period. (Reinforcement Phase)

Study Type

Interventional

Enrollment (Anticipated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Community Pharmacist

Exclusion Criteria:

  • Less than four hours of daily work in community pharmacy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Didactic Lecture
2 sessions of didactic lecture with PowerPoint presentations each delivered by a special lecturer. whole education period lasts 3 hours.
Experimental: Lecture plus Case Disscussion
2 sessions of brief interactive lectures followed by case discussion sections.
Experimental: Lecture plus Small Group Education
A 1.5 hours session of didactic lecture followed by a session of small group education with 3 simulated patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Grade Points and Attitudes(Phase 1)
Time Frame: One day
Obtained through a validated knowledge and attitude questionnaire.
One day
Knowledge Grade Points and Attitudes(Phase 2)
Time Frame: One month(average of 4 weeks after the day of training)
Obtained through a validated knowledge and attitude questionnaire.
One month(average of 4 weeks after the day of training)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction of Participants
Time Frame: One day
Obtained by a Satisfaction Evaluation Questionnaire.
One day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Kheirollah Gholami, M.Sc, PharmD, Tehran University Of Medical Sciences
  • Principal Investigator: Amir Sarayani, PharmD, MPH, Tehran University Of Medical Sciences
  • Principal Investigator: Arash Rashidian, MD, PhD, Tehran University Of Medical Sciences
  • Principal Investigator: Mohammadreza Javadi, PharmD, BCPS, Tehran University Of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

April 15, 2011

First Submitted That Met QC Criteria

April 19, 2011

First Posted (Estimate)

April 20, 2011

Study Record Updates

Last Update Posted (Estimate)

July 26, 2011

Last Update Submitted That Met QC Criteria

July 25, 2011

Last Verified

July 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • 240/4402

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Didactic Lecture

3
Subscribe